Is Lucid Diagnostics Inc. (LUCD) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 11.6% / 30% | 12.2% / 30% | 0.2% / 30% | 7.41% / 5% | ✗ NOT HALAL |
| DJIM | 11.6% / 33% | 12.2% / 33% | 0.2% / 33% | 7.41% / 5% | ✗ NOT HALAL |
| MSCI | 69.2% / 33% | 72.8% / 33% | 1.3% / 33% | 7.41% / 5% | ✗ NOT HALAL |
| S&P | 11.6% / 33% | 12.2% / 33% | 0.2% / 33% | 7.41% / 5% | ✗ NOT HALAL |
| FTSE | 69.2% / 33% | 72.8% / 33% | 1.3% / 50% | 7.41% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | -41.7% | |
| Operating Margin | -931.6% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -710.6% | |
| Return on Assets (ROA) | -87.2% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$44M |
| Free Cash Flow | -$45M |
| Total Debt | $21M |
| Debt-to-Equity | 236.1 |
| Current Ratio | 1.3 |
| Total Assets | $31M |
Price & Trading
| Last Close | $1.15 |
| 50-Day MA | $1.29 |
| 200-Day MA | $1.16 |
| Avg Volume | 1.3M |
| Beta | 1.2 |
|
52-Week Range
$0.95
| |
About Lucid Diagnostics Inc. (LUCD)
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. It focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. The company's flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. operates as a subsidiary of PAVmed Inc.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Lucid Diagnostics Inc. (LUCD) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Lucid Diagnostics Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Lucid Diagnostics Inc.'s debt ratio?
Lucid Diagnostics Inc.'s debt ratio is 11.6% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 69.2%.
What are Lucid Diagnostics Inc.'s key financial metrics?
Lucid Diagnostics Inc. has a market capitalization of $191M, and revenue of $4M. Return on equity stands at -710.6%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.